SeaCrest Wealth Management’s AIM ImmunoTech AIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-351
Closed -$4.29K 709
2025
Q1
$4.29K Hold
351
﹤0.01% 657
2024
Q4
$6.94K Hold
351
﹤0.01% 654
2024
Q3
$9.47K Hold
351
﹤0.01% 650
2024
Q2
$13.1K Hold
351
﹤0.01% 613
2024
Q1
$16.5K Sell
351
-20
-5% -$829 ﹤0.01% 602
2023
Q4
$16.3K Hold
371
﹤0.01% 618
2023
Q3
$16.9K Hold
371
﹤0.01% 618
2023
Q2
$24.8K Hold
371
﹤0.01% 622
2023
Q1
$15.9K Hold
371
﹤0.01% 627
2022
Q4
$11.6K Sell
371
-30
-7% -$1.39K ﹤0.01% 632
2022
Q3
$23K Hold
401
﹤0.01% 619
2022
Q2
$31K Hold
401
﹤0.01% 1323
2022
Q1
$42K Buy
401
+15
+4% +$1.29K ﹤0.01% 703
2021
Q4
$35K Sell
386
-50
-11% -$7.73K ﹤0.01% 703
2021
Q3
$88K Hold
436
0.01% 660
2021
Q2
$94K Hold
436
0.01% 681
2021
Q1
$99K Sell
436
-53
-11% -$12K 0.01% 645
2020
Q4
$87K Sell
489
-17
-3% -$3.4K 0.01% 605
2020
Q3
$109K Buy
506
+40
+9% +$9.99K 0.02% 560
2020
Q2
$115K Buy
+466
New +$113K 0.02% 528

Other funds holding AIM

SeaCrest Wealth Management's AIM Position: Q2 2025 in Review

SeaCrest Wealth Management sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 351 shares — an estimated $4.29K sold.

SeaCrest Wealth Management first reported a position in AIM in Q2 2020 and held it in 20 quarters. The position peaked at $115K in Q2 2020. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

  • SeaCrest Wealth Management reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
  • SeaCrest Wealth Management sold 351 AIM ImmunoTech shares in Q2 2025, an estimated $4.29K.
  • SeaCrest Wealth Management first reported a position in AIM ImmunoTech in Q2 2020 and held it in 20 quarters.
  • SeaCrest Wealth Management's AIM ImmunoTech position peaked at $115K in Q2 2020.
  • 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on SeaCrest Wealth Management's 13F filing for Q2 2025, filed 11 Jul 2025.